Medicine
Methergine 0.2 mg tablet
Methergine 0.2 mg tablet is a prescription medicine containing Methylergonovine for oral use, marketed by Lupin, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store below 25°C (77°F), in tight, light-resistant container.
Key facts
- Active ingredient (INN)
- Methylergonovine
- Brand
- Methergine
- Strength
- 0.2 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 28 tablets, 12 tablets
- Marketing authorisation holder
- Lupin
- Manufacturer
- LupinIndia
- Origin register
- US FDA, United States
- Storage
- Store below 25°C (77°F), in tight, light-resistant container.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- G02AB01 Methylergonovine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 4 April 2016
- Identifiers
- RxCUI 996824, 996826DailyMed set ID 3f04ca06-fe52-46d6-96cd-2e77ef6fa36fNDC 27437-050Application ANDA091577
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 19 November 1946 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Methylergonovine 0.2 mg tablet.
Other strengths and forms of Methylergonovine
Clinical summary
Methylergonovine is an ergot derivative. It is available as tablets and injection for oral, intravenous and intramuscular use. MedsAcross supplies Methylergonovine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MethylergonovineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Methylergonovine Maleate prescribing information (Granules India) · U.S. National Library of Medicine, DailyMed
Need Methergine 0.2 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.